Clinical Trial Update: Evaluating Genes in Sputum to Measure Drug Response in COPD [NA]

View source ↗

Summary

A National Jewish Health-sponsored COPD trial evaluating sputum gene expression as a biomarker for drug response has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: National Jewish Health | Conditions: Chronic Obstructive Pulmonary Disease (COPD), Emphysema | NA | Status: TERMINATED